Institutions Holding Call Options on Corvus Pharmaceuticals, Inc. (CRVS)
This table provides information about the call option holders of Corvus Pharmaceuticals, Inc. (CRVS). We have compiled data on the institutions that hold call options on the stock, with a total of 1.06 Million call options outstanding, which have been reported (via 13F filing form) to have a value of $5.08 Million at the end of the reported quarter. These call option holders have the right, but not the obligation, to buy AAPL shares at a specified price within a certain time frame.
| Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
500,000
calls
|
$2.4 Million
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Nov 14, 2024 Q3 2024 |
218,300
calls
|
$1.05 Million
0.2% of portfolio
|
Q3 2024
New holding
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
152,800
calls
|
$733,440
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Boothbay Fund Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
63,800
calls
|
$306,240
0.01% of portfolio
|
Q3 2024
New holding
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
58,900
calls
|
$282,720
0.0% of portfolio
|
N/A
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2024 Q3 2024 |
37,600
calls
|
$180,480
0.0% of portfolio
|
N/A
|
|
|
Wolverine Trading, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
27,500
calls
|
$132,000
0.0% of portfolio
|
N/A
|